Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CON vs EHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHC Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

EHC Overall Winner 6-Pillar Tally: CON 1 – 5 EHC Matrix Metrics: CON 3 – 7 EHC

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Concentra Group Holdings Parent, Inc. (CON) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CON carries a Unified Composite Score of 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CON vs EHC
CON NYSE
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
TTM Revenue $2.34B
Forward P/E 22.0x
Beta / 30D Vol 0.52β · 38% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 56
RSI-14: 55.6 · SMA20: $41.80 · SMA50: $38.66
EHC NYSE Head-to-Head Winner
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15

6-Pillar Scorecard Institutional Category Breakdown (CON 1 – 5 EHC)

Columns: Metric · CON · EHC
1. Valuation Multiples EHC
Forward P/E 22.0x 19.4x
Trailing P/E 24.5x 21.2x
PEG Ratio N/M 0.41x
EV / Revenue 3.1x 2.5x
2. Growth & Scale EHC
Revenue Growth (YoY) +8.6% +8.9%
Earnings Growth (YoY) +36.4% +21.6%
TTM Revenue (USD) $2.34B $6.34B
Market Cap $5.2B $13.0B
3. Profitability & Quality EHC
Gross Margin 29.9% 44.1%
Operating Margin 17.2% 18.4%
Net Profit Margin 9.3% 10.2%
Return on Equity (ROE) 47.2% 25.1%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $257M $457M
Cash Flow Margin 11.0% 7.2%
Net Cash / Leverage $2.04B Net Debt (4.20x D/E) $2.73B Net Debt (1.05x D/E)
Dividend Yield 0.60% 0.58%
5. Options & Positioning CON
Options Structure Phase BREAKOUT CONSOLIDATION
Current IV / %ile 269.9% (95th %ile) 27.0% (8th %ile)
Put/Call OI Skew 0.79x (Call-Skewed) 0.25x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 12.7% of Rev ($297M) 25.7% of Rev ($1.63B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CON (3) vs EHC (7)
Institutional Metric CON EHC Criterion Row Edge
Market Capitalization
Scale
$5.2B $13.0B Larger Scale EHC
Trailing P/E Ratio
Valuation
24.5x 21.2x Lower Multiple EHC
Forward P/E Ratio
Valuation
22.0x 19.4x Lower Multiple EHC
Revenue Growth (YoY)
Growth
+8.6% +8.9% Higher Growth EHC
Operating Margin (TTM)
Profitability
17.2% 18.4% Higher Margin EHC
Net Profit Margin
Profitability
9.3% 10.2% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
47.2% 25.1% Higher ROE CON
52-Week Range Position
Momentum
91% ($19–$44) 80% ($93–$144) Stronger Trend CON
Beta / 30D Volatility
Risk Regime
0.52β · 38% Vol -0.10β · 40% Vol Lower Realized Risk CON
Unified Institutional Score
Composite Signal
43.5 / 100 (HOLD) 52.0 / 100 (HOLD) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$2.34B $6.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
29.9% 44.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.1x EV/Rev 0.41x PEG · 2.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$257M ($2.04B Net Debt (4.20x D/E)) $457M ($2.73B Net Debt (1.05x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +1.38 pp
CON: +4.68% · EHC: +6.06%
3M Horizon CON +9.05 pp
CON: +19.58% · EHC: +10.53%
6M Horizon CON +37.91 pp
CON: +65.24% · EHC: +27.33%
1Y Horizon CON +98.16 pp
CON: +117.58% · EHC: +19.42%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CON Revenue EHC Revenue CON Op. Margin EHC Op. Margin Margin Leader
FY2018 N/A $4.28B N/A 13.0% EHC
FY2019 N/A $4.61B N/A 13.3% EHC
FY2020 N/A $3.57B N/A 15.8% EHC
FY2021 N/A $4.01B N/A 13.9% EHC
FY2022 $1.72B $4.35B 15.0% 12.4% CON
FY2023 $1.84B $4.80B 15.6% 7.3% CON
FY2024 $1.90B $5.37B 16.0% 8.5% CON
FY2025 $2.16B $5.94B 15.4% 9.5% CON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CON BREAKOUT
99d in phase · OBV NEUTRAL
Current IV 269.9%
IV Percentile 95th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CON Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 12.7% of Rev ($297M)
90D Engineering Disclosures 0 Published
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published

Investor FAQ CON vs EHC Key Questions & Quantitative Answers

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Concentra Group Holdings Parent, Inc. (CON) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CON carries a Unified Composite Score of 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin). Technically, CON sits in a Markup phase (RSI 55.6, BREAKOUT options structure) and EHC sits in a Neutral phase (RSI 49.8, CONSOLIDATION options structure).

EHC leads the Growth & Scale pillar: CON posts +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin), compared with EHC at +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CON cumulative revenue shifted +25.6% while EHC shifted +38.8%. In operating R&D and SG&A reinvestment, CON deploys 12.7% of Rev ($297M) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($1.63B) (0 disclosures) for EHC.

EHC screens cheaper on headline valuation multiples. CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin), whereas EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CON (47.2% ROE) versus EHC (25.1% ROE) capital efficiency.

In options market volatility and institutional positioning, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk). By comparison, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.